Symbol Name ID |
Slc39a5
solute carrier family 39 (metal ion transporter), member 5 MGI:1919336 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Slc39a5tm1.1Gka/Slc39a5tm1.1Gka involves: 129P2/OlaHsd * C57BL/6 * FVB/N |
abnormal liver zinc level | J:209760 |
abnormal zinc homeostasis | J:209760 | |
increased susceptibility to induced pancreatitis | J:209760 | |
pancreatic acinar cell atrophy | J:209760 | |
Slc39a5tm1b(KOMP)Wtsi/Slc39a5tm1b(KOMP)Wtsi C57BL/6N-Slc39a5tm1b(KOMP)Wtsi/Ucd |
decreased circulating serum albumin level | J:211773 |
increased bone mineral density | J:211773 | |
increased circulating alkaline phosphatase level | J:211773 | |
Slc39a5tm1Gka/Slc39a5tm1Gka Tg(Cela1-cre/ERT)1Lgdn/0 involves: 129P2/OlaHsd * C57BL/6 |
abnormal zinc homeostasis | J:209760 |
decreased liver iron level | J:209760 | |
increased susceptibility to induced pancreatitis | J:209760 | |
pancreatic acinar cell atrophy | J:209760 | |
Slc39a5tm1Gka/Slc39a5tm1Gka Tg(Vil1-cre/ERT2)23Syr/0 involves: 129P2/OlaHsd * C57BL/6 * DBA/2 |
abnormal zinc homeostasis | J:209760 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|